VR goggles may ease anxiety and improve sleep for COPD patients in the ICU
NCT ID NCT07475650
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether using virtual reality (VR) glasses for 30 minutes each evening could improve sleep quality, reduce anxiety, and stabilize vital signs in intensive care patients with COPD. Fifty patients were split into two groups: one received VR sessions for a week, the other received standard care. Sleep and anxiety were measured using standard scales, and vital signs were tracked before and after each session.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
virtual reality glasses
What this could lead to
If it works, this could offer a simple, drug-free way to help ICU patients with COPD sleep better and feel less anxious during their hospital stay.
What could go wrong
This is a small, completed study with only 50 participants. The results may not apply to all COPD patients or other hospital settings. The effect may be modest and not a substitute for medical treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Health Sciences Erciyes University
Kayseri, Melikgazi, 38260, Turkey (Türkiye)